Date: 2021-10-13
Type of information: Production agreement
Compound: AAV-mediated gene therapies
Company: Lexeo Therapeutics (USA-NY) Fujifilm Diosynth (USA-TX)
Therapeutic area: Rare diseases - Genetic diseases -Neurodegenerative diseases - Cardiovascular diseases
Type agreement: manufacturing bioproduction
Action mechanism: gene therapy
Disease:
Details:
Financial terms:
Latest news: